Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation

BACKGROUND: Although trastuzumab provides significant clinical benefit for HER2-positive breast cancers, responses are limited by the emergence of resistance. Recent evidence suggests that long noncoding RNAs (lncRNAs) play important roles in tumorigenesis and chemoresistance. However, the regulator...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Mingli, Gu, Yuanting, Lu, Pengwei, Li, Jingyi, Cao, Hui, Li, Xiangke, Qian, Xueke, Yu, Chao, Yang, Yunqing, Yang, Xue, Han, Na, Dou, Dongwei, Hu, Jianguo, Dong, Huaying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001272/
https://www.ncbi.nlm.nih.gov/pubmed/32020881
http://dx.doi.org/10.1186/s12943-020-1145-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001272/
https://www.ncbi.nlm.nih.gov/pubmed/32020881
http://dx.doi.org/10.1186/s12943-020-1145-5

Ejemplares similares